{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T10:51:12Z","timestamp":1783075872666,"version":"3.54.6"},"reference-count":60,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2014,3,10]],"date-time":"2014-03-10T00:00:00Z","timestamp":1394409600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0091775","type":"journal-article","created":{"date-parts":[[2014,3,10]],"date-time":"2014-03-10T20:49:13Z","timestamp":1394484553000},"page":"e91775","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":17,"title":["The Effects of LPM570065, a Novel Triple Reuptake Inhibitor, on Extracellular Serotonin, Dopamine and Norepinephrine Levels in Rats"],"prefix":"10.1371","volume":"9","author":[{"given":"Renyu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufeng","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaoxiang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengying","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanhui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingji","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youxin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,3,10]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1056\/NEJMra073096","article-title":"Major depressive disorder","volume":"358","author":"R Belmaker","year":"2008","journal-title":"New Engl J Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1056\/NEJMra050730","article-title":"The medical management of depression","volume":"353","author":"JJ Mann","year":"2005","journal-title":"New Engl J Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1517\/13543784.2011.594039","article-title":"Triple reuptake inhibitors for treating subtypes of major depressive disorder: the monoamine hypothesis revisited","volume":"20","author":"J Prins","year":"2011","journal-title":"Expert Opin Inv Drug"},{"key":"ref4","first-page":"9","article-title":"Symptoms of fatigue and sleepiness in major depressive disorder","volume":"67","author":"DS Baldwin","year":"2005","journal-title":"J Clin Psychiat"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.4088\/JCP.v67n1113","article-title":"A cross-sectional study of the prevalence of cognitive and physical symptoms during long-term antidepressant treatment","volume":"67","author":"M Fava","year":"2006","journal-title":"J Clin Psychiat"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1001\/archpsyc.1992.01820060027004","article-title":"Marked reduction in indexes of dopamine metabolism among patients with depression who attempt suicide","volume":"49","author":"A Roy","year":"1992","journal-title":"Arch Gen Psychiat"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/S0006-3223(02)01383-5","article-title":"Dopaminergic abnormalities in amygdaloid nuclei in major depression: a postmortem study","volume":"52","author":"V Klimek","year":"2002","journal-title":"Biol Psychiat"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"337","DOI":"10.4088\/JCP.v65n0308","article-title":"Citalopram and bupropion-SR: combining versus switching in patients with treatment-resistant depression","volume":"65","author":"RW Lam","year":"2004","journal-title":"J Clin Psychiat"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.4088\/JCP.v66n1012","article-title":"Olanzapine\/fluoxetine combination for treatment-resistant depression: a controlled study of SSRI and nortriptyline resistance","volume":"66","author":"SA Corya","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1001\/archpsyc.64.3.327","article-title":"The role of dopamine in the pathophysiology of depression","volume":"64","author":"BW Dunlop","year":"2007","journal-title":"Arch Gen Psychiat"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1056\/NEJMoa052964","article-title":"Medication augmentation after the failure of SSRIs for depression","volume":"354","author":"MH Trivedi","year":"2006","journal-title":"New Engl J Med"},{"key":"ref12","first-page":"13","article-title":"Sexual functioning and SSRIs","volume":"63","author":"M Fava","year":"2002","journal-title":"J Clin Psychiat"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.euroneuro.2008.07.011","article-title":"The triple monoaminergic reuptake inhibitor DOV 216,303 has antidepressant effects in the rat olfactory bulbectomy model and lacks sexual side effects","volume":"18","author":"M Breuer","year":"2008","journal-title":"Eur Neuropsychopharm"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1017\/S1461145707008383","article-title":"Functional interactions between dopamine, serotonin and norepinephrine neurons: an <italic>in-vivo<\/italic> electrophysiological study in rats with monoaminergic lesions","volume":"11","author":"BP Guiard","year":"2008","journal-title":"Int J Neuropsychoph"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1177\/026988110001400202","article-title":"Reciprocal autoreceptor and heteroreceptor control of serotonergic, dopaminergic and noradrenergic transmission in the frontal cortex: relevance to the actions of antidepressant agents","volume":"14","author":"MJ Millan","year":"2000","journal-title":"J Psychopharmacol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1017\/S1461145710000076","article-title":"Characterization of the electrophysiological properties of triple reuptake inhibitors on monoaminergic neurons","volume":"14","author":"BP Guiard","year":"2011","journal-title":"Int J Neuropsychoph"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.neuroscience.2011.08.064","article-title":"Preclinical pharmacology of TP1, a novel potent triple reuptake inhibitor with antidepressant properties","volume":"196","author":"JW Tian","year":"2011","journal-title":"Neuroscience"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2165\/11594710-000000000-00000","article-title":"Clinically significant drug interactions with newer antidepressants","volume":"26","author":"E Spina","year":"2012","journal-title":"CNS Drugs"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1046\/j.1471-4159.2001.00275.x","article-title":"Control of serotonergic neurons in rat brain by dopaminergic receptors outside the dorsal raphe nucleus","volume":"77","author":"R Mart\u00edn-Ruiz","year":"2001","journal-title":"J Neurochem"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/0166-2236(90)90107-L","article-title":"Functional architecture of basal ganglia circuits: neural substrates of parallel processing","volume":"13","author":"GE Alexander","year":"1990","journal-title":"Trends Neurosci"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0079-6123(08)62678-3","article-title":"Basal ganglia-thalamocortical circuits: parallel substrates for motor, oculomotor, \u201cprefrontal\u201d and \u201climbic\u201d functions","volume":"85","author":"GE Alexander","year":"1991","journal-title":"Prog Brain Res"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S0006-8993(01)02934-1","article-title":"The role of the habenular complex in the elevation of dorsal raphe nucleus serotonin and the changes in the behavioral responses produced by uncontrollable stress","volume":"917","author":"J Amat","year":"2001","journal-title":"Brain Res"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1111\/j.1460-9568.2007.05581.x","article-title":"Challenging the omnipotence of the suprachiasmatic timekeeper: are circadian oscillators present throughout the mammalian brain?","volume":"25","author":"C Guilding","year":"2007","journal-title":"Eur J Neurosci"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.neubiorev.2007.01.004","article-title":"A conductor hidden in the orchestra? Role of the habenular complex in monoamine transmission and cognition","volume":"31","author":"L Lecourtier","year":"2007","journal-title":"Neurosci Biobehav R"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.bbr.2007.08.021","article-title":"Electrolytic lesions of the habenula attenuate brain stimulation reward","volume":"187","author":"MC Morissette","year":"2008","journal-title":"Behav Brain Res"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/cne.1340","article-title":"Two types of projection neurons in the internal pallidum of primates: Single-axon tracing and three-dimensional reconstruction","volume":"439","author":"M Parent","year":"2001","journal-title":"J Comp Neurol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1017\/S1092852900016710","article-title":"The lateral habenula: no longer neglected","volume":"13","author":"S Geisler","year":"2008","journal-title":"CNS Spectr"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1126\/science.1240729","article-title":"\u03b2CaMKII in Lateral Habenula Mediates Core Symptoms of Depression","volume":"341","author":"K Li","year":"2013","journal-title":"Science"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1124\/jpet.106.103382","article-title":"Desvenlafaxine succinate: a new serotonin and norepinephrine reuptake inhibitor","volume":"318","author":"DC Deecher","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.brainres.2006.04.057","article-title":"Pharmacokinetic and pharmacodynamic profiles of the novel serotonin and norepinephrine reuptake inhibitor desvenlafaxine succinate in ovariectomized Sprague-Dawley rats","volume":"1098","author":"PD Alfinito","year":"2006","journal-title":"Brain Res"},{"key":"ref31","unstructured":"Paxinos G, Watson C (2007) The rat brain in stereotaxic coordinates. sixth ed. Manhattan: Academic Press."},{"key":"ref32","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0003-2697(02)00435-9","article-title":"Simultaneous determination of norepinephrine, serotonin, and 5-hydroxyindole-3-acetic acid in microdialysis samples from rat brain by microbore column liquid chromatography with fluorescence detection following derivatization with benzylamine","volume":"312","author":"T Yoshitake","year":"2003","journal-title":"Anal Biochem"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jchromb.2004.03.069","article-title":"Determination of serotonin, noradrenaline, dopamine and their metabolites in rat brain extracts and microdialysis samples by column liquid chromatography with fluorescence detection following derivatization with benzylamine and 1, 2-diphenylethylenediamine","volume":"807","author":"T Yoshitake","year":"2004","journal-title":"J Chromatogr B"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"e69934","DOI":"10.1371\/journal.pone.0069934","article-title":"Maternal Deprivation Enhances Behavioral Vulnerability to Stress Associated with miR-504 Expression in Nucleus Accumbens of Rats","volume":"8","author":"Y Zhang","year":"2013","journal-title":"PLOS ONE"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.neuroscience.2011.03.020","article-title":"Serotonergic neurotransmission in the ventral hippocampus is enhanced by corticosterone and altered by chronic amphetamine treatment","volume":"182","author":"JL Barr","year":"2011","journal-title":"Neuroscience"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1111\/j.1476-5381.2011.01499.x","article-title":"Mephedrone, compared with MDMA (ecstasy) and amphetamine, rapidly increases both dopamine and 5-HT levels in nucleus accumbens of awake rats","volume":"164","author":"J Kehr","year":"2011","journal-title":"Brit J Pharmacol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1177\/026988110201600403","article-title":"Comparison of the effects of antidepressants on norepinephrine and serotonin concentrations in the rat frontal cortex: an <italic>in-vivo<\/italic> microdialysis study","volume":"16","author":"CE Beyer","year":"2002","journal-title":"J Psychopharmacol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1111\/j.1476-5381.2011.01770.x","article-title":"Preclinical and clinical characterization of the selective 5-HT<sub>1A<\/sub> receptor antagonist DU-125530 for antidepressant treatment","volume":"167","author":"M Scorza","year":"2012","journal-title":"Brit J Pharmacol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/S0022-3565(25)38637-4","article-title":"Central pre-and postsynaptic 5-HT<sub>1A<\/sub> receptors in rats treated chronically with a novel antidepressant, cericlamine","volume":"268","author":"T Jolas","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/S0022-3565(25)10650-2","article-title":"Effects of acute and repeated administration of antidepressant drugs on extracellular levels of 5-hydroxytryptamine measured <italic>in vivo<\/italic>","volume":"274","author":"DS Kreiss","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0028-3908(99)00088-X","article-title":"Differential adaptation of brain 5-HT<sub>1A<\/sub> and 5-HT<sub>1B<\/sub> receptors and 5-HT transporter in rats treated chronically with fluoxetine","volume":"39","author":"E Le Poul","year":"2000","journal-title":"Neuropharmacology"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1002\/jps.20542","article-title":"Enzymes involved in the bioconversion of ester-based prodrugs","volume":"95","author":"BM Liederer","year":"2006","journal-title":"J Pharm Sci"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0165-6147(02)02017-5","article-title":"Assessing antidepressant activity in rodents: recent developments and future needs","volume":"23","author":"JF Cryan","year":"2002","journal-title":"Trends Pharmacol Sci"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1527-3458.2006.00123.x","article-title":"Preclinical and clinical pharmacology of DOV 216,303, a \u201ctriple\u201d reuptake inhibitor","volume":"12","author":"P Skolnick","year":"2006","journal-title":"CNS Drug Rev"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ejphar.2004.09.057","article-title":"Involvement of dopamine receptors in the anti-immobility effects of dopamine re-uptake inhibitors in the forced swimming test","volume":"504","author":"J Yamada","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/00019442-200108000-00015","article-title":"Methylphenidate augmentation of citalopram in elderly depressed patients","volume":"9","author":"H Lavretsky","year":"2001","journal-title":"Am J Geriat Psychiat"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.4088\/JCP.v64n1202","article-title":"Combined treatment with methylphenidate and citalopram for accelerated response in the elderly: an open trial","volume":"64","author":"H Lavretsky","year":"2003","journal-title":"J Clin Psychiat"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"291","DOI":"10.31887\/DCNS.2008.10.3\/pgorwood","article-title":"Neurobiological mechanisms of anhedonia","volume":"10","author":"P Gorwood","year":"2008","journal-title":"Dialogues Clin Neurosci"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1177\/026988110201600205","article-title":"Effect of chronic fluoxetine and WAY-100635 treatment on serotonergic neurotransmission in the frontal cortex","volume":"16","author":"L Dawson","year":"2002","journal-title":"J Psychopharmacol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/sj.bjp.0705800","article-title":"Effects of chronic treatment with escitalopram or citalopram on extracellular 5-HT in the prefrontal cortex of rats: role of 5-HT<sub>1A<\/sub> receptors","volume":"142","author":"I Ceglia","year":"2004","journal-title":"Brit J Pharmacol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1124\/jpet.106.111690","article-title":"D<sub>2<\/sub>-like dopamine receptors depolarize dorsal raphe serotonin neurons through the activation of nonselective cationic conductance","volume":"320","author":"TK Aman","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1046\/j.0953-816x.2001.01616.x","article-title":"D<sub>2<\/sub>-like dopamine receptor activation excites rat dorsal raphe 5-HT neurons <italic>in vitro<\/italic>","volume":"14","author":"S Haj-Dahmane","year":"2001","journal-title":"Eur J Neurosci"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0014-2999(98)00321-5","article-title":"Involvement of dopamine D<sub>2<\/sub> receptors in apomorphine-induced facilitation of forebrain serotonin output","volume":"351","author":"A Mendlin","year":"1998","journal-title":"Eur J Pharmacol"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1177\/0269881107077347","article-title":"Reciprocal effects of combined administration of serotonin, noradrenaline and dopamine reuptake inhibitors on serotonin and dopamine levels in the rat prefrontal cortex: the role of 5-HT<sub>1A<\/sub> receptors","volume":"21","author":"P Weikop","year":"2007","journal-title":"J Psychopharmacol"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/syn.21531","article-title":"Effects of the triple reuptake inhibitor amitifadine on extracellular levels of monoamines in rat brain regions and on locomotor activity","volume":"66","author":"K Golembiowska","year":"2012","journal-title":"Synapse"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0014-2999(03)01310-4","article-title":"Antidepressant-like actions of DOV 21,947: a \u201ctriple\u201d reuptake inhibitor","volume":"461","author":"P Skolnick","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1124\/jpet.107.133132","article-title":"The triple uptake inhibitor (1R, 5S)-(+)-1-(3, 4-dichlorophenyl)-3-azabicyclo [3.1. 0] hexane hydrochloride (DOV 21947) reduces body weight and plasma triglycerides in rodent models of diet-induced obesity","volume":"324","author":"JP Tizzano","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jpsychires.2011.09.003","article-title":"Efficacy and tolerability of the novel triple reuptake inhibitor amitifadine in the treatment of patients with major depressive disorder: a randomized, double-blind, placebo-controlled trial","volume":"46","author":"P Tran","year":"2012","journal-title":"J Psychiat Res"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1038\/sj.npp.1300506","article-title":"Discovering endophenotypes for major depression","volume":"29","author":"G Hasler","year":"2004","journal-title":"Neuropsychopharmacol"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.nurt.2008.10.039","article-title":"Dual-and triple-acting agents for treating core and co-morbid symptoms of major depression: novel concepts, new drugs","volume":"6","author":"MJ Millan","year":"2009","journal-title":"Neurotherapeutics"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0091775","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T01:02:02Z","timestamp":1746147722000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0091775"}},"subtitle":[],"editor":[{"given":"Hideyuki","family":"Sawada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,3,10]]},"references-count":60,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2014,3,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0091775","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,10]]}}}